novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning
On Oct. 22, 2026, a first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come…
-
-
New formulation helps RNA vaccines withstand high temperatures
On Sept. 28, 2026, Massachusetts Institute of Technology (MIT) engineers announced finding a way to stabilize the lipid…
-
FDA approves Moderna’s New mRNA-based influenza vaccine for adults
On Aug. 6, 2026, the Food and Drug Administration announced it has approved a new kind of flu…
-
FDA panel backs first-of-its-kind flu vaccine using mRNA technology
On Jun. 18, 2026, a new kind of flu vaccine moved a step closer to the U.S. market…
-
Biotechnology | Diagnostics | FDA | Neurology
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
-
EMA recommends Moderna’s combined mRNA vaccine for protecting older adults against COVID-19 and flu
On Feb. 27, 2026, the European Medicines Agency (EMA) announced it’s recommending marketing authorization for mCombriax, Moderna’s combined…
-
first side-by-side comparison of how three major COVID-19 vaccines trigger immune responses
On Dec. 2, 2025, a Northwestern Medicine led study provided the first side-by-side comparison of how three major…
-
Sanofi to acquire Vicebio for $1.15 Billion, expanding respiratory vaccines pipeline
On Jul. 22, 2025, Sanofi announces it has entered into an agreement to acquire Vicebio, a privately held…
-
Houston Zoo Elephant Received First Ever mRNA EEHV Vaccine
On Jun. 18, 2024, the Houston Zoo announced that Tess, a 40-year-old Asian elephant at the Zoo, had…
-
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
-
COVID-19 | CRISPR | Therapeutics | Vaccine
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
-
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
-
Pfizer and BioNTech submitted a variation to EMA for vaccination of children ages 6 months to less than 5 Years with COMIRNATY
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
-
CDC reported effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19 among children and adolescents
On Mar. 1, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that two doses of Pfizer-BioNTech…
-
BioNTech planned to initiate construction of an mRNA vaccine manufacturing facility in Africa in mid-2022
On Oct. 26, 2021, BioNTech announce that the Company planned to initiate the construction of the first state-of-the-art…
-
COVID-19 booster increased antibody responses, was protective in rhesus macaques
On Oct. 21, 2021, the National Institutes of Health (NIH) announced that a booster dose of the mRNA-1273…
-
Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
On Oct. 7, 2021, Moderna announced it will build a state-of-the-art mRNA facility in Africa with the goal…
-
Emergent BioSolutions announced manufacturing agreement with Providence Therapeutics for mRNA COVID-19 vaccine candidate
On Sept. 14, 2021, Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development…
-
2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
-
Moderna and Canada announced collaboration to bring mRNA manufacturing to Canada
On Aug. 10, 2021, the government of Canada The Government of Canada announced it had established a memorandum…
-
10 million doses of mRNA-based COVID-19 vaccine supplied to Taiwan Region
On Jul. 12, 2021, BioNTech announced that Fosun Industrial Co. had reached advance procurement agreements for the mRNA-based…
-
WHO supported South African consortium to establish first COVID mRNA vaccine technology transfer hub
On Oct. 6, 2021, the World Health Organization (WHO) and its COVAX partners are working with a South…
-
Moderna partnered with Takeda and Government of Japan to supply 50 million doses of mRNA vaccine against COVID-19
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
-
UK MHRA began rolling review of Moderna’s mRNA COVID-19 vaccine
On Oct. 28, 2020, The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced it had begun the…
-
Moderna completed enrollment of phase 3 COVE study of mRNA vaccine against COVID-19
On Oct. 22, 2020, Moderna announced that it had completed enrollment of 30,000 participants for the Phase 3…
-
Pfizer and BioNTech announced publication of phase 1 data on lead mRNA vaccine candidate against COVID-19
On Oct. 14, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from the Phase 1 portion of…
-
Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
-
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
-
BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
-
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
